ArticleFrontiers in immunology2022

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma.

Jialiang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.